Omeprazole Capsule, Delayed Release
Product Images NDC 70700-151

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Omeprazole (NDC 70700-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of Omeprazole, showing the molecular arrangement including a benzimidazole ring system with a methoxy group, a sulfoxide functional group, and a pyridine ring with methyl and methoxy substituents.*

FDA Label Image

Ome-10mg-30count (Ome 10mg 30count)

Label for Omeprazole Delayed-Release Capsules, USP, 10 mg strength, oral capsule dosage form. The package contains 30 capsules, labeled for prescription use by Xiromed, LLC. Storage instructions and handling precautions are provided. The label displays the NDC 70700-149-30 and notes the product is made in Spain.*

FDA Label Image

Ome-20mg-30count (Ome 20mg 30count)

Label for Omeprazole Delayed-Release Capsules, USP 20 mg by Xiromed, LLC. The package contains 30 capsules and is labeled for Rx only. Storage instructions and warnings are included, along with the labeler's address in Florham Park, NJ, and manufacturing origin in Spain. NDC 70700-150-30 is shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.